Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3553 studies found for:    Open Studies | "Brain Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy
Condition: Covert Hepatic Encephalopathy
Intervention: Drug: Rifaximin
2 Recruiting Magnetic Resonance Biomarkers in Neonatal Encephalopathy
Condition: Neonatal Encephalopathy
Intervention:
3 Recruiting Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin
4 Recruiting Sildenafil Administration to Treat Neonatal Encephalopathy
Condition: Neonatal Encephalopathy
Interventions: Drug: Sildenafil;   Drug: Ora-Blend
5 Not yet recruiting Mild Encephalopathy in the Newborn Treated With Darbepoetin
Conditions: Neonatal Encephalopathy;   Hypoxic-Ischemic Encephalopathy Mild
Interventions: Drug: Darbepoetin Alfa;   Drug: Normal Saline
6 Recruiting PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Polyethylene Glycol
7 Recruiting Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study
Condition: Hepatic Encephalopathy
Intervention: Biological: Fecal Microbiota Transplant
8 Recruiting Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
Condition: Encephalopathy, Hepatic
Interventions: Drug: Nitazoxanide;   Drug: Lactulose
9 Recruiting Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)
Condition: Hepatic Encephalopathy
Interventions: Other: Prospective Phase Rifaximin-α 550mg;   Other: Prospective Phase No Rifaximin-α 550mg;   Other: Retrospective Phase
10 Recruiting A Study of the Genetic Analysis of Brain Disorders
Condition: Brain Disorders
Intervention:
11 Not yet recruiting High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit.
Condition: Refractory Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Rifaximin;   Biological: Plasmapheresis
12 Recruiting Prognostic Observation of Posterior Reversible Encephalopathy Syndrome
Condition: Posterior Reversible Encephalopathy Syndrome
Intervention:
13 Recruiting A Multi-Center Cohort Study of Risk Factors and Outcomes of Encephalopathy of Prematurity in China
Condition: Encephalopathy
Intervention:
14 Recruiting Hypothermia for Encephalopathy in Low and Middle-Income Countries Trial
Condition: Neonatal Encephalopathy
Intervention: Device: Whole body cooling (Tecotherm)
15 Recruiting Cannabidiol in Children With Refractory Epileptic Encephalopathy
Condition: Epileptic Encephalopathy
Intervention: Drug: CanniMed® 1:20
16 Recruiting Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy
Conditions: Neonatal Encephalopathy;   Hypoxic-ischemic Encephalopathy
Intervention: Other: Autologous umbilical cord blood cells
17 Recruiting Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning
Condition: Delayed Encephalopathy After Carbon Monoxide Poisoning
Interventions: Biological: Human cord blood mononuclear cell;   Other: hyperbaric oxygen
18 Recruiting Hyperbaric Oxygen Therapy Improves Outcome of Hypoxic-Ischemic Encephalopathy
Condition: Hypoxic-ischemic Encephalopathy
Intervention: Device: hyperbaric oxygen
19 Recruiting Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI
Condition: Brain Diseases
Intervention: Drug: Dotarem
20 Recruiting Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy
Condition: Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy)
Intervention: Biological: Autologous cord blood cell therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.